Event-Driven Stocks

CORNING CLINICAL LABORATORIES INC

Other · SEC filings ↗ · Compare ⊕

Signs● 4 gooddetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$11.04B$9.87B$9.25B$9.88B$10.79B$9.44B
Operating income$1.56B$1.35B$1.26B$1.43B$2.38B$1.97B
Net income$992.0M$871.0M$854.0M$946.0M$2.00B$1.43B
Total assets$16.23B$16.15B$14.02B$12.84B$13.61B$14.03B
Total liabilities——————
Equity$7.17B$6.78B$6.31B$5.89B$6.44B$6.76B
EPS (diluted)$8.75$7.69$7.49$7.97$15.55$10.47
Shares out.111.0M110.7M111.3M119.5M133.5M133.5M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
14.1%
Net margin
9.0%
Return on equity
13.8%
Return on assets
6.1%
Return on capital (ROCE)
11.2%
Liabilities / assets
—
Debt / equity
—
Book value / share
$64.61
Revenue growth (YoY)
11.8%
Net income growth (YoY)
13.9%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Accruals / assets
−5.5%clean
Piotroski F-Score
6/8mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
87
/ 100
Profitability 100Growth 100Catalyst 33Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 4 good
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (3)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.